UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) ~~of the~~

of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): ~~June~~July 624, 2025

AMERISAFE, INC.

(Exact Name of Registrant as Specified in ~~its~~ Charter)


Texas	001-12251	75-2069407
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

2301 Highway 190 West

DeRidder, Louisiana 70634

(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code: (337) 463-9052

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions (see General Instruction A.2. below):

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered or to be registered pursuant to Section 12(b) of the Act:

Title of each class				TradingSymbol(s)				Name of eachexchange on which registered
Common Stock, par value $0.01 per share				AMSF				Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

~~Item 5.02.~~Securities ~~Departure~~registered ~~of Directors~~ or ~~Certain~~to ~~Officers;~~be ~~Election~~registered ofpursuant ~~Directors;~~to ~~Appointment~~Section 12(b) of ~~Certain~~the ~~Officers; Compensatory Arrangements of Certain Officers~~Act.

On June 6, 2025, AMERISAFE, Inc. (the “Company”) held its 2025 annual meeting of shareholders (the “2025 Annual Meeting”). At the 2025 Annual Meeting, as further described below under Item 5.07 of this Current Report on Form 8-K (this “Report”), the Company’s shareholders approved an amendment to the Company’s Non-Employee Director Restricted Stock Plan (as amended, the “Director Plan”) in part to increase the number of shares of the Company’s common stock available for issuance thereunder by 50,000 shares and to increase the maximum annual target value of restricted stock that may be granted to each non-employee director to $200,000. Other than the foregoing, the terms of the Director Plan remain substantially the same. The Director Plan is administered by the Company’s Board of Directors (the “Board”) and provides for automatic grants of restricted stock to the Company’s non-employee directors on an annual basis and upon a non-employee director’s initial appointment to the Board.


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.01 per share	AMSF	Nasdaq Stock Market LLC

~~A more detailed description of the principal features of the Director Plan can be found under Proposal 4 in the Company’s proxy statement on Schedule 14A filed with the U~~Item 8.S01. ~~Securities~~Other ~~and~~Events Exchange Commission (the “SEC”) on April 30, 2025 (the “2025 Proxy Statement”). The foregoing description of the Director Plan is not complete and is subject to, and qualified in its entirety by reference to, the full text of such plan, which is filed as Exhibit 10.1 to this Form 8-K and incorporated herein by reference.

~~Item 5~~On July 24, 2025, AMERISAFE, Inc.07 (the “Company”) issued a press release announcing that its Board of Directors (the “Board”) reauthorized the $25.0 million ~~Submission~~share repurchase program that replaces its prior share repurchase program with no expiration date. As of ~~Matters~~July 24, to2025, a$25.0 million ~~Vote~~was available for future repurchases of ~~Security~~the ~~Holders~~Company’s common stock under the share repurchase program.

~~The~~Share repurchases under the Company’s ~~held~~share repurchase program may be affected from time to time pursuant to trading plans meeting the ~~2025~~requirements ~~Annual~~of ~~Meeting~~Rule on10b5-1 ~~June 6~~under the Exchange Act of 1934, ~~2025~~as atamended. ~~the~~The Company’s ~~corporate~~share ~~headquarters~~repurchase inprogram ~~DeRidder,~~does ~~Louisiana.~~not ~~All~~obligate ~~matters~~the ~~submitted~~Company ~~for~~to ~~approval~~repurchase byany shares of the Company’s ~~shareholders,~~common asstock ~~described~~and inmay ~~the~~be ~~2025~~modified, ~~Proxy~~increased, ~~Statement~~suspended, ~~were~~or ~~approved~~terminated at the ~~2025~~discretion ~~Annual~~of ~~Meeting~~the Board. The Board’s determination will depend on a variety of factors, including but not limited to, market conditions and applicable regulatory considerations. It is anticipated that any future repurchases will be funded from available capital.

Of the 19,050,315 shares of the Company’s common stock outstanding as of the 2025 Annual Meeting record date on April 17, 2025, 18,023,934 shares were represented in person or by proxy at the 2025 Annual MeetingItem 9.01. ~~The~~Financial ~~inspector~~Statements ofand ~~election~~Exhibits ~~reported the final vote of the shareholders as follows:~~

1. Election of directors. The following director nominees were elected for terms expiring at the Company’s 2028 annual meeting of shareholders:

Name	Votes For	Votes Withheld	Broker Non-Votes
Teri G. Fontenot	17,022,091	486,703	515,140
Billy B. Greer	16,942,054	566,740	515,140
Jared A. Morris	15,429,856	2,078,938	515,140

2. Advisory vote to approve the Company’s compensation of its named executive officers. The compensation of the Company’s named executive officers, as disclosed in the Company’s 2025 proxy statement under “Executive Compensation” and discussed under “Compensation Discussion and Analysis,” was approved on an advisory basis.

Votes For		Votes Against		Abstentions		Broker Non-Votes
16,780,464		726,212		2,118		515,140

3. Ratification of appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for 2025. The appointment of Ernst & Young was ratified.

Votes For		Votes Against		Abstentions
17,690,631		331,505		1,798

4. Approval of an amendment to the Company’s Non-Employee Director Restricted Stock Plan to increase the number of authorized shares issuable under the Plan. The amendment to the Company’s Non-Employee Director Restricted Stock Plan was approved.

Votes For		Votes Against		Abstentions		Broker Non-Votes
17,204,784		302,177		1,833		515,140

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit Number		Description
Exhibit No.		Description
10.1		AMERISAFE, Inc. 2025 Non-Employee Director Restricted Stock Plan (incorporated by reference to Appendix A to the Company’s Proxy Statement on Schedule 14A filed April 30, 2025)
99.1		Press Release of AMERISAFE, Inc. dated July 24, 2025 (Share Repurchase Program)
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the ~~registrant~~Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

AMERISAFE, INC. By: /s/ ~~Kathryn~~Anastasios H.Omiridis ~~Shirley~~Anastasios ~~Kathryn~~Omiridis, ~~H. Shirley~~ Executive Vice President, and Chief ~~Administrative~~Financial Officer ~~and Secretary~~

Date: ~~June~~July 924, 2025

Filing Compare · AMERISAFE INC